# Abbott Laboratories (ABT) — Q3-2024 Earnings Results

**Report date:** 2024-10-16 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q3-2024

## Post-Earnings Brief

### Headline

Abbott Labs Beats on EPS, Stock Up 1.53%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.21 | N/A | +1.00% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting operational efficiency as a key focus. They remain cautiously optimistic about future performance.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on maintaining strong operational efficiency.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Abbott Labs reported a slight beat on EPS, which contributed to a positive stock reaction, with shares rising 1.53%. The lack of revenue data and guidance leaves some uncertainty about future performance. Investors may take the EPS beat as a sign of resilience in the current market environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q3-2024_